Investment Summary |
|
|---|---|
| Date | 2021-01-14 |
| Target | NewAmsterdam Pharma |
| Sector | Life Science |
| Investor(s) | EQT Life Sciences |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 33 of 47 |
| Sector: Life Science M&A | 19 of 30 |
| Type: Venture M&A Deals | 27 of 39 |
| Country: Netherlands M&A | 10 of 10 |
| Year: 2021 M&A | 1 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-09 |
VICO Therapeutics
Leiden, Netherlands Vico Therapeutics is developing therapies for rare neurological diseases, leveraging RNA modifying technologies. VICO Therapeutics was founded in 2019 and is based in Leiden, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-20 |
Neurent Medical
Galway, Ireland Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive parasympathetic nerves that drive underlying inflammation. Neurent Medical is based in Galway, Ireland. |
Buy | - |
